Form 4: AEHR VP Sporck Reports Future RSU Tax Withholding
Statement of Changes in Beneficial Ownership
Aehr Test Systems VP Alistair Sporck filed a Form 4 detailing a future transaction of 239 shares withheld for tax obligations upon RSU vesting.
Summary
- Alistair N. Sporck, VP Contactor Business Unit at Aehr Test Systems (AEHR), filed a Form 4 reporting a planned transaction.
- On January 11, 2026, 239 shares of Common Stock are scheduled to be disposed of at a price of $26.32 per share.
- This disposition represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs) and is not a sale by the reporting person.
- Following this transaction, Mr. Sporck will beneficially own 28,692 shares directly and 5,214 shares indirectly through a trust.
- The reported amount of beneficially owned shares includes those subject to unvested restricted stock units.
- The transaction is made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
Sentiment
Score: 5
Explanation: The filing is a routine compliance report detailing a pre-planned, non-discretionary transaction related to executive compensation and tax withholding. It does not contain information that would significantly alter the company's financial outlook or operational performance, thus warranting a neutral sentiment.
Positives
- The transaction indicates the vesting of restricted stock units for a key executive, which is a positive for the executive's compensation and retention.
Negatives
- A minor reduction of 239 shares in direct beneficial ownership due to tax withholding, which is a routine administrative event and not a market sale.
Future Outlook
The filing details a pre-planned transaction scheduled for January 11, 2026, under a Rule 10b5-1 plan, involving the withholding of shares for tax purposes upon RSU vesting. This indicates a future compensation event for the executive.
Industry Context
This Form 4 filing is a routine compliance disclosure for an executive of a publicly traded company in the semiconductor test equipment industry. It reflects standard executive compensation practices involving restricted stock units and associated tax obligations, rather than a strategic industry development.
Comparison to Industry Standards
- The use of restricted stock units (RSUs) as part of executive compensation is a common practice across the technology and semiconductor industries, aligning executive incentives with shareholder value.
- The withholding of shares to cover tax obligations upon RSU vesting is a standard administrative procedure, consistent with practices observed at comparable companies like Teradyne (TER) or Cohu (COHU) for their executive compensation plans.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Authorization | A Power of Attorney was executed on June 2, 2023, by Alistair N. Sporck, authorizing Gayn Erickson, Chris Siu, Adil Engineer, and Vernon Rogers to complete and execute Forms 3, 4, and 5 on his behalf for Section 16 reporting. | 06/02/2023 | This authorization streamlines the executive's compliance with SEC reporting requirements, ensuring timely and accurate filings for changes in beneficial ownership. |
Stakeholder Impact
- Shareholders: Minimal impact due to a small number of shares (239) being withheld for tax purposes, which is a routine administrative event and not a market sale.
- Employees (specifically Alistair N. Sporck): The vesting of RSUs and subsequent tax withholding is a standard part of executive compensation, reflecting the realization of equity awards.
Next Steps
- The planned transaction of 239 shares for tax withholding is scheduled to occur on January 11, 2026.
Key Dates
| Date | Description |
|---|---|
| 06/02/2023 | Power of Attorney executed by Alistair N. Sporck, authorizing designated individuals to file Section 16 reports. |
| 01/11/2026 | Date of planned transaction where 239 shares of Common Stock will be withheld for tax obligations upon RSU vesting. |
| 01/12/2026 | Date the Form 4 was signed by the Attorney-in-Fact. |
Keywords
AEHR, Aehr Test Systems, Form 4, insider transaction, Alistair Sporck, restricted stock units, RSU vesting, tax withholding, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.